Customer Center
Login | Register

Investor Relations

Investor Relations

Stock Information

More >>

Recent News

More >>
Date Title  
Toggle Summary Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
AUSTIN, Texas , Nov. 4, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019 . All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP").
Toggle Summary Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019
AUSTIN, Texas , Oct. 25, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close.  The company will host a conference call that day at 5:00 p.m.

Events & Presentations

More >>
Date Event Details
Summary Toggle 11/04/19 5:00 PM EST Monday, November 04, 2019 5:00 PM EST
Summary Toggle 10/02/19 2:50 PM EDT Wednesday, October 02, 2019 2:50 PM EDT